Heart stent trial tests cutting blood thinner time in half
Disease control
Recruiting now
This study is observing 2,000 real-world patients with heart disease who receive a specific drug-coated stent (VIVO ISAR) and are prescribed a short course of blood thinners (3 months or less). The goal is to collect safety and performance data on this stent when used with this s…
Sponsor: Translumina Therapeutics Pvt Ltd. • Aim: Disease control
Last updated Apr 01, 2026 23:11 UTC